Neuronal structures associated with memory sprout in response to novel molecules
Drug candidates protect neurons against damage from substance implicated in Alzheimer's disease
Jessica Cifelli
The study looked at the effect of drug candidates on the density of tiny thornlike structures called dendritic spines that bristle along the branching processes of neurons and receive incoming signals.
"Problems with learning and memory in many neurodegenerative and neurodevelopment disorders, such as Alzheimer's disease and certain forms of autism or mental retardation involve either loss or misregulation of dendritic spines," said Jerry Yang, a professor of chemistry and biochemistry who led the work. "The compounds we have developed may offer the possibility to compensate, or ideally preserve, neuronal communication in people suffering from problems with memory."
When the researchers treated neurons from a part of the brain critical to forming and retrieving memories with their new compounds they saw an increase in the density of dendritic spines. The new compounds also prevented the loss of these spines that occurs in the presence of amyloid-beta, the substance that forms amyloid plaques in the brains of people with Alzheimer's disease, the team reports in a forthcoming issue of the Journal of Biological Chemistry.
The greater the concentration of the drug candidate, the greater the density of spines within the range of doses the team tested. The effect is also reversible: once the compounds were washed away, the spines receded within 24 hours.
Earlier versions of these compounds, also developed by Yang's research group, improved memory and learning in normal mice and a mouse model for Alzheimer's disease, but were too toxic to pursue as drug candidates.
Jessica Cifelli, a graduate student in Yang's group, worked out a way to keep the part of the molecules that they believe promoted the growth of dendritic spines, but alter the chemical features that impart toxicity. These novel compounds, called benzothiazole amphiphiles, are new tools to study relationship between dendritic spines and cognitive behavior.
We know from a wealth of prior research that spine densities on neurons change over time and that increases in the densities correlate with improved memory and learning. As potential drugs, benzothiazole amphiphiles could be useful for combatting spine loss in neurodegenerative disease, or possibly for general cognitive enhancement.
Topics
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.